| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT07421167 A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice… |
date change Primary completion pushed: 2027-03-03 -> 2029-01-10 |
| 2026-06-12 | NCT07421167 A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice… |
date change Completion pushed: 2027-03-31 -> 2030-09-18 |
| 2026-06-09 | NCT07039422 Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody… |
Trial sites expanded: 18 -> 22 locations |
| 2026-06-06 | NCT06470048 A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic… |
date change Completion pushed: 2030-07-15 -> 2034-07-31 |
| 2026-06-06 | NCT06293365 Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of… |
date change Primary completion pushed: 2025-06-05 -> 2026-02-17 |
| 2026-05-27 | NCT07039422 Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody… |
Trial sites expanded: 14 -> 18 locations |
| 2026-05-15 | NCT05350072 Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active… |
date change Completion moved earlier: 2027-05-06 -> 2026-06-02 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-02 | NCT07621809 Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus… | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06711887 | Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study… | Lupus Nephritis | Recruiting |
| NCT06133972 | Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With… | Systemic Lupus Erythematosus | Recruiting |
| NCT05653349 | Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary… | Primary Immune Thrombocytopenia (ITP) | Active, Not Recruiting |
| NCT05985915 | A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension… | Sjogrens Syndrome | Active, Not Recruiting |
| NCT05350072 | Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active… | Sjogren Syndrome | Active, Not Recruiting |
| NCT05653219 | A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in… | Primary Immune Thrombocytopenia | Active, Not Recruiting |
| NCT07621809 | Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus… | Sjögren´s Disease | Not Yet Recruiting |
| NCT05349214 | Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With… | Sjogren Syndrome | Active, Not Recruiting |
| NCT05624749 | Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With… | Systemic Lupus Erythematosus | Active, Not Recruiting |
| NCT05639114 | Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in… | Systemic Lupus Erythematosus | Active, Not Recruiting |
| NCT05648968 | A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm… | Warm Autoimmune Hemolytic Anemia (wAIHA) | Active, Not Recruiting |
| Phase 2 | |||
| NCT06470048 | A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic… | Diffuse Cutaneous Systemic Sclerosis | Recruiting |
| NCT07039422 | Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody… | Primary Immune Thrombocytopenia | Recruiting |
| NCT07421167 | A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice… | Primary Immune Thrombocytopenia (ITP) | Recruiting |
| NCT03827798 | Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to… | Hidradenitis Suppurativa | Active, Not Recruiting |
| NCT05885555 | A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP)… | Primary Immune Thrombocytopenia (ITP) | Active, Not Recruiting |
| NCT06293365 | Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of… | Sjögrens Disease | Active, Not Recruiting |